Coronavirus: What Happened When The Vaccine Was Tested On Monkeys?

A few weeks ago, we covered a blog on Coronavirus: Special Training For Dogs To Detect Coronavirus In Humans where dogs are being trained to smell the coronavirus. Today, we will look into more about the results of a new vaccine which was tested on monkeys and how the hopes to end the coronavirus has changed after these results. Read more to learn more about the vaccine that was tested on these monkeys and how this vaccine could affect human testing in the future.

What Has Been Achieved?

Another milestone has been achieved with the coronavirus vaccine as the United States made a vaccine that protects monkeys. Beth Israel Deaconess Medical Center (BIDMC) in Boston, USA, has been successful in its research where this vaccine was tested on the rhesus macaque. Increased numbers of antibodies in the body of vaccinated monkeys have been found to completely or largely eliminate the coronavirus and prevent its production.

“Administering our vaccine in the first participants of this clinical trial is a significant achievement, bringing us one step closer toward addressing the fundamental need for a vaccine in the fight against the global COVID‑19 pandemic.” – Stanley C. Erck (President and Chief Executive Officer of Novavax)

Stated on Novavax

35 days after inoculation, researchers also tested a coronavirus spray on the nose of these monkeys. Laboratory virologist Dane Barroch says the vaccine has destroyed the virus and that these results prove that humans can also develop a strong, long-lasting immunity against the coronavirus. Soon, humans will be injected as the next trial of studies.

Updates On Human-Testing

Novavax, an American vaccine company, has announced that they will now test their coronavirus vaccine in humans. The successful coronavirus vaccine, NVX-CoV2373, was developed last April and has now moved on from their first phase of vaccination. Results for first phase will be available in July on the efficacy and safety of the vaccine. Regarding Phase 2, Novavax will begin trials on humans in several countries, including US and Australia (131 volunteers).

Their recent success with the coronavirus vaccine on monkeys can definitely been seen on the stock market. The stock price for Novavax (Symbol: NVAX) has recently skyrocketed for a series of 12 days from May 6th to May 18th. The stock has calmed down since then as the hype went down about this news.

I hope you really enjoyed your way through my content and please don’t forget to subscribe to the blog down below and leave a comment. Please make sure to join our Facebook Group where you have the opportunity to connect with us and also a chance to regularly keep up with our updates. Thanks a lot and I will meet you’ll soon!!!

Peace Out!!!

Please Subscribe to Top Tamil Talk

Receive FREE newsletters delivered directly to your inbox!

Success! You're on the list.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s